CME presentation slides on Antepartum Haemorrhage
Bleeding from or in to the genital tract, occurring from 24
weeks (>500g) of pregnancy and prior to the birth of the
baby
Antepartum hemorrhage (APH) refers to vaginal bleeding during pregnancy after 24 weeks of gestation and accounts for 2-5% of pregnancies. The main causes of APH are placenta previa, abruptio placenta, and other less common causes. Placenta previa and abruptio placenta are managed by ensuring maternal and fetal stability, considering delivery if either is abnormal, and preventing postpartum hemorrhage. Vasa previa, a rare condition, involves rupture of fetal vessels below the presenting part and requires emergency c-section if bleeding occurs after rupture of membranes.
This document discusses antepartum haemorrhage (APH), defined as bleeding from or into the genital tract occurring from 22 weeks of pregnancy until birth. APH complicates 3-5% of pregnancies and is a leading cause of perinatal and maternal mortality. The main causes of APH are placenta praevia, abruptio placentae, vasa praevia, and local cervical/vaginal bleeding. Management involves stabilizing the mother, assessing fetal wellbeing, investigating the cause, and planning for delivery depending on gestational age and the condition of the mother and fetus.
Antepartum haemorrhage (APH) is bleeding from or into the genital tract occurring between 24 weeks of pregnancy until birth. The most common causes are placenta praevia and placental abruption. APH complicates 3-5% of pregnancies and is a leading cause of perinatal and maternal mortality worldwide. Management of APH involves assessing the severity of bleeding and signs of shock, investigating the cause, monitoring the fetus, and considering conservative management or delivery depending on gestational age and stability of the mother and fetus. Definitive treatment depends on the specific cause and can involve induction, vaginal delivery, or caesarean section.
This document defines antepartum haemorrhage (APH) as bleeding from or into the genital tract occurring after 22 weeks of pregnancy but before birth. APH complicates 3-5% of pregnancies and is a leading cause of perinatal and maternal mortality. The main causes of APH are placenta praevia, abruptio placenta, and vasa praevia. Placenta praevia is when the placenta implants over or near the cervical opening and is diagnosed using ultrasound. Abruptio placenta occurs when the placenta separates from the uterus prematurely. Vasa praevia occurs when fetal blood vessels in the membranes are not supported by
This document defines antepartum haemorrhage (APH) as bleeding from or into the genital tract occurring from 22 weeks of pregnancy until birth. APH complicates 3-5% of pregnancies and is a leading cause of perinatal and maternal mortality. The main causes of APH are placenta praevia, abruptio placentae, vasa praevia, and excessive show. Management involves assessing maternal and fetal stability, investigating to determine the cause, monitoring closely, and deciding whether expectant management or delivery is required based on gestational age and severity of bleeding.
This document discusses antepartum haemorrhage (APH), defined as bleeding from or into the genital tract occurring after 22 weeks of pregnancy but before birth. APH complicates 3-5% of pregnancies and is a leading cause of perinatal and maternal mortality. The main causes of APH are placenta praevia, abruptio placentae, vasa praevia, and local cervical/vaginal bleeding of unknown origin. Management depends on the severity and cause of bleeding, and may involve bed rest, steroids, monitoring, blood transfusions, or delivery by vaginal birth or caesarean section.
Antepartum hemorrhage (APH) is bleeding from the genital tract during pregnancy before labor. It affects 4% of pregnancies and can cause complications for both mother and fetus. The main causes are placenta previa, placental abruption, and local infections. Management depends on severity, with minor bleeding monitored but major bleeding requiring delivery to stabilize the mother or fetus. Expediting delivery preserves the health of both.
01.1_aph_6th_year_seminar_grp_aa in ism Kyrgyzstanthxz2fdqxw
This document discusses the management of obstetric hemorrhage including antepartum and postpartum hemorrhage. It defines the various causes of hemorrhage including placenta previa, abruption, and morbidly adherent placenta. It outlines the evaluation and treatment approach including vital sign monitoring, ultrasound assessment, bloodwork, and management strategies depending on the cause and gestational age. Emergency interventions like blood transfusion and cesarean delivery are discussed as critical to stabilizing both mother and fetus in hemorrhage events.
Antepartum hemorrhage (APH) refers to vaginal bleeding during pregnancy after 24 weeks of gestation and accounts for 2-5% of pregnancies. The main causes of APH are placenta previa, abruptio placenta, and other less common causes. Placenta previa and abruptio placenta are managed by ensuring maternal and fetal stability, considering delivery if either is abnormal, and preventing postpartum hemorrhage. Vasa previa, a rare condition, involves rupture of fetal vessels below the presenting part and requires emergency c-section if bleeding occurs after rupture of membranes.
This document discusses antepartum haemorrhage (APH), defined as bleeding from or into the genital tract occurring from 22 weeks of pregnancy until birth. APH complicates 3-5% of pregnancies and is a leading cause of perinatal and maternal mortality. The main causes of APH are placenta praevia, abruptio placentae, vasa praevia, and local cervical/vaginal bleeding. Management involves stabilizing the mother, assessing fetal wellbeing, investigating the cause, and planning for delivery depending on gestational age and the condition of the mother and fetus.
Antepartum haemorrhage (APH) is bleeding from or into the genital tract occurring between 24 weeks of pregnancy until birth. The most common causes are placenta praevia and placental abruption. APH complicates 3-5% of pregnancies and is a leading cause of perinatal and maternal mortality worldwide. Management of APH involves assessing the severity of bleeding and signs of shock, investigating the cause, monitoring the fetus, and considering conservative management or delivery depending on gestational age and stability of the mother and fetus. Definitive treatment depends on the specific cause and can involve induction, vaginal delivery, or caesarean section.
This document defines antepartum haemorrhage (APH) as bleeding from or into the genital tract occurring after 22 weeks of pregnancy but before birth. APH complicates 3-5% of pregnancies and is a leading cause of perinatal and maternal mortality. The main causes of APH are placenta praevia, abruptio placenta, and vasa praevia. Placenta praevia is when the placenta implants over or near the cervical opening and is diagnosed using ultrasound. Abruptio placenta occurs when the placenta separates from the uterus prematurely. Vasa praevia occurs when fetal blood vessels in the membranes are not supported by
This document defines antepartum haemorrhage (APH) as bleeding from or into the genital tract occurring from 22 weeks of pregnancy until birth. APH complicates 3-5% of pregnancies and is a leading cause of perinatal and maternal mortality. The main causes of APH are placenta praevia, abruptio placentae, vasa praevia, and excessive show. Management involves assessing maternal and fetal stability, investigating to determine the cause, monitoring closely, and deciding whether expectant management or delivery is required based on gestational age and severity of bleeding.
This document discusses antepartum haemorrhage (APH), defined as bleeding from or into the genital tract occurring after 22 weeks of pregnancy but before birth. APH complicates 3-5% of pregnancies and is a leading cause of perinatal and maternal mortality. The main causes of APH are placenta praevia, abruptio placentae, vasa praevia, and local cervical/vaginal bleeding of unknown origin. Management depends on the severity and cause of bleeding, and may involve bed rest, steroids, monitoring, blood transfusions, or delivery by vaginal birth or caesarean section.
Antepartum hemorrhage (APH) is bleeding from the genital tract during pregnancy before labor. It affects 4% of pregnancies and can cause complications for both mother and fetus. The main causes are placenta previa, placental abruption, and local infections. Management depends on severity, with minor bleeding monitored but major bleeding requiring delivery to stabilize the mother or fetus. Expediting delivery preserves the health of both.
01.1_aph_6th_year_seminar_grp_aa in ism Kyrgyzstanthxz2fdqxw
This document discusses the management of obstetric hemorrhage including antepartum and postpartum hemorrhage. It defines the various causes of hemorrhage including placenta previa, abruption, and morbidly adherent placenta. It outlines the evaluation and treatment approach including vital sign monitoring, ultrasound assessment, bloodwork, and management strategies depending on the cause and gestational age. Emergency interventions like blood transfusion and cesarean delivery are discussed as critical to stabilizing both mother and fetus in hemorrhage events.
This document discusses causes and management of antepartum haemorrhage (APH). The main causes are placenta praevia (20%), abruptio placentae (30%), and indeterminate (45%). Management involves resuscitation, identifying the cause using ultrasound, and managing the specific cause. Placenta praevia risks include prematurity and PPH. Abruptio placentae risks include fetal death from inadequate oxygen. Women with prior c-sections are at increased risk of morbidly adherent placenta. Indeterminate APH requires delivery by 40 weeks due to possible minor abruptio.
Obstetric emergencies are life-threatening conditions that can affect pregnant women and their babies. Examples include antepartum hemorrhage (APH), obstructed labor, preeclampsia, and postpartum hemorrhage. APH refers to bleeding from the vagina after 28 weeks of gestation but before birth. Placenta previa, where the placenta covers all or part of the cervix, is a common cause of APH. Risk factors for placenta previa include advanced maternal age, smoking, and prior cesarean sections. Management of placenta previa depends on severity but may include bed rest, monitoring, blood transfusions, and ultimately delivery by cesare
Antepartum hemorrhage (APH) is vaginal bleeding occurring between 24 weeks of pregnancy and birth. It affects 3-5% of pregnancies and can range from light spotting to heavy bleeding with signs of shock. The main causes are placenta previa, placental abruption, and unknown origins. APH poses risks to both mother and fetus, including anemia, infection, shock, and fetal hypoxia. Diagnosis involves examination, ultrasound, and tests. Management depends on gestational age and severity of bleeding, and may involve admission, monitoring, resuscitation, corticosteroids, tocolysis, and delivery.
This document discusses various causes of obstetric haemorrhage including placenta praevia, abruptio placentae, uterine rupture, and vasa previa. It provides details on the definition, risk factors, clinical presentation, diagnosis, and management of each condition. Placenta praevia is defined as a placenta implanted in the lower uterus and is a leading cause of late pregnancy bleeding. Abruptio placentae is the premature detachment of a normally situated placenta before delivery. Uterine rupture is a complete separation of the uterine wall while vasa previa occurs when fetal vessels traverse the membranes over the cervical os. Immediate surgical intervention is often required to treat bleeding
Bleeding in early pregnancy can be due to miscarriage, ectopic pregnancy, or other causes. Signs and symptoms may include vaginal bleeding, abdominal or pelvic pain, and a positive pregnancy test. Evaluation involves assessing the last menstrual period, risk factors, ultrasound findings, and serum hCG levels. Management depends on the diagnosis and clinical situation, and may involve expectant monitoring, medical treatment with misoprostol or methotrexate, or surgical evacuation. The goal is to identify life-threatening ectopic pregnancies while preserving future fertility when possible.
This document discusses antepartum haemorrhage (APH), defined as bleeding from or into the genital tract between 22 weeks of pregnancy and birth. It affects 3-5% of pregnancies and is a leading cause of perinatal mortality. The main causes of APH are placenta praevia, abruptio placentae, vasa praevia, and local cervical/vaginal bleeding. Management depends on severity and etiology, and may include bed rest, corticosteroids, monitoring, blood transfusion, and delivery by vaginal birth or caesarean section.
Postpartum hemorrhage (PPH) is excessive bleeding following childbirth. It is a leading cause of maternal mortality, accounting for nearly 1/4 of maternal deaths worldwide. The most common cause is uterine atony, or failure of the uterus to contract after delivery. Other causes include retained placenta, trauma during delivery, coagulation disorders, and issues like placenta previa. Risk factors include previous PPH, macrosomia, multiple pregnancy, and uterine overdistention. Prevention focuses on risk assessment and active management of the third stage of labor. Treatment depends on the severity but may include uterine massage, uterotonic drugs, uterine packing, arterial ligation, embolization, compression sutures
Postpartum hemorrhage (PPH) is excessive bleeding following childbirth. It is a leading cause of maternal mortality, accounting for nearly one quarter of maternal deaths worldwide. The most common cause is uterine atony, or failure of the uterus to contract after delivery. Other causes include retained placenta, trauma during delivery, coagulation disorders, and issues like placenta previa. Risk factors include previous PPH, macrosomia, multiple pregnancy, and uterine overdistention. Prevention focuses on risk assessment and active management of the third stage of labor. Treatment depends on the severity but may include uterine massage, uterotonic drugs, uterine packing, arterial ligation, embolization, compression sutures,
Antepartum haemorrhage (APH) is bleeding from the genital tract between 28 weeks of pregnancy until birth. Placental causes account for 70% of APH cases, with placenta previa being the most common cause, occurring in 35% of placental APH cases. Placenta previa is when the placenta implants partially or completely in the lower uterine segment. It is diagnosed using ultrasound and managed either expectantly until 37 weeks if mild, or through caesarean section, especially for posterior placenta previa or heavy bleeding. Management depends on the amount of bleeding, maternal and fetal condition, and gestational age.
Antepartum haemorrhage (APH), or bleeding during pregnancy, can be caused by placenta praevia or abruption. Placenta praevia occurs when the placenta implants in the lower uterine segment, potentially causing bleeding as the cervix dilates. Abruption occurs when the placenta prematurely separates from the uterine wall, and bleeding severity is classified from mild to severe. APH is considered an obstetric emergency treated initially with IV fluids and monitoring, with management depending on gestational age and bleeding severity, and potentially involving delivery.
This document discusses two cases of high risk obstetrics. Case 1 involves a woman at 34 weeks gestation presenting with abdominal pain and bleeding. Her examination and investigations indicate signs of placental abruption. Case 2 involves a woman at 34.5 weeks gestation with a history of two previous cesarean sections and placenta previa diagnosed at 21 weeks. Her examination and ultrasound confirm placenta previa and possible placenta accreta. The document then discusses various questions related to the differential diagnosis, risk factors, complications, management, and delivery approach for conditions like placental abruption and placenta previa.
This document discusses placenta previa and placenta accreta spectrum. It begins with definitions of placenta previa as implantation of the placenta over the internal cervical os. It describes placenta accreta spectrum from accreta where the placenta attaches to the myometrium without decidua, to increta with invasion into the myometrium, and percreta with invasion through the myometrium. Risk factors include placenta previa, cesarean sections, advanced maternal age, and previous uterine surgeries. Ultrasound is the main diagnostic tool but MRI can also be used. Management involves multidisciplinary care, conservative approaches when possible
Antepartum haemorrhage (APH), or bleeding during pregnancy, can be caused by placenta praevia or abruption placentae. Placenta praevia occurs when the placenta implants in the lower uterine segment, potentially causing bleeding as the cervix dilates. Abruptio placentae involves premature separation of a normally implanted placenta from the uterus, and risks include hypertension, smoking, and trauma. APH is a medical emergency treated initially with IV fluids and blood transfusions, with management depending on gestational age and severity of bleeding, potentially involving bed rest, corticosteroids, or caesarean delivery.
1) Antepartum haemorrhage is defined as bleeding from or into the genital tract after 28 weeks of pregnancy but before birth. Placenta praevia and abruption placentae are two common causes.
2) Placenta praevia occurs when the placenta implants partially or fully in the lower uterine segment. It can cause painless vaginal bleeding and is diagnosed using ultrasound.
3) Abruption placentae is the premature separation of a normally implanted placenta and can cause abdominal pain with concealed or mixed internal and external bleeding. It is commonly associated with preeclampsia.
This document discusses various causes of antepartum hemorrhage (APH), including placenta previa, abruption placentae, and vasa previa. Placenta previa, where the placenta implants in the lower uterine segment, accounts for about one-third of APH cases. Risk factors include advancing maternal age, multiparity, prior cesarean delivery, and smoking. Management depends on gestational age and severity of bleeding, ranging from bed rest to cesarean delivery. Abruptio placentae is the premature separation of a normally implanted placenta and can cause concealed or revealed bleeding. It is associated with increased risks of fetal and maternal complications. Vasa previa
This document discusses third-trimester bleeding during pregnancy. It can be caused by conditions like abruptio placentae (AP), placenta previa (PP), and vasa previa (VP). AP is the premature separation of the placenta from the uterine wall. PP is the presence of placental tissue over the cervical os. VP occurs when umbilical cord vessels lie in the membranes over the cervical os. These conditions can lead to significant maternal and fetal risks if not properly managed. The document outlines the epidemiology, etiology, complications, diagnosis, and management considerations for each condition.
This document discusses the evaluation and management of a 37-year-old pregnant female presenting with vaginal bleeding. The differential diagnosis includes placenta previa. Ultrasound confirms placenta previa. The types of placenta previa and risk factors are discussed. As the bleeding increases and vital signs deteriorate, urgent delivery by cesarean section is required to stabilize the patient.
Late pregnancy bleeding can be caused by placental, fetal, or maternal factors. Placental causes include placental abruption and placenta previa. Initial evaluation includes assessing vital signs, fetal heart tones, nature of bleeding, and ultrasound to locate the placenta. Placental abruption involves premature separation of the placenta and can range from mild to severe. Placenta previa occurs when the placenta covers all or part of the cervical os, posing risks of hemorrhage. Morbidly adherent placenta like placenta accreta involves abnormal invasion of the placenta into the uterine wall. Vasa previa is a rare condition where fetal vessels cross the internal
anti partum hemorrhage and its complicationdevtesfaye77
1. Antepartum hemorrhage (APH) refers to vaginal bleeding after 28 weeks of gestation until delivery. The leading causes are placental abruption and placenta previa. Placental abruption is the premature separation of a normally implanted placenta and can range from mild to severe based on the extent of separation. Placenta previa involves the placenta covering or lying adjacent to the cervical os, posing a risk of painless bleeding. Less common, vasa previa occurs when fetal blood vessels lie over the cervical os.
2. Diagnosis involves clinical presentation as well as ultrasound and laboratory testing. Management depends on severity, gestational age and maternal-fetal
Mercurius is named after the roman god mercurius, the god of trade and science. The planet mercurius is named after the same god. Mercurius is sometimes called hydrargyrum, means ‘watery silver’. Its shine and colour are very similar to silver, but mercury is a fluid at room temperatures. The name quick silver is a translation of hydrargyrum, where the word quick describes its tendency to scatter away in all directions.
The droplets have a tendency to conglomerate to one big mass, but on being shaken they fall apart into countless little droplets again. It is used to ignite explosives, like mercury fulminate, the explosive character is one of its general themes.
This document discusses causes and management of antepartum haemorrhage (APH). The main causes are placenta praevia (20%), abruptio placentae (30%), and indeterminate (45%). Management involves resuscitation, identifying the cause using ultrasound, and managing the specific cause. Placenta praevia risks include prematurity and PPH. Abruptio placentae risks include fetal death from inadequate oxygen. Women with prior c-sections are at increased risk of morbidly adherent placenta. Indeterminate APH requires delivery by 40 weeks due to possible minor abruptio.
Obstetric emergencies are life-threatening conditions that can affect pregnant women and their babies. Examples include antepartum hemorrhage (APH), obstructed labor, preeclampsia, and postpartum hemorrhage. APH refers to bleeding from the vagina after 28 weeks of gestation but before birth. Placenta previa, where the placenta covers all or part of the cervix, is a common cause of APH. Risk factors for placenta previa include advanced maternal age, smoking, and prior cesarean sections. Management of placenta previa depends on severity but may include bed rest, monitoring, blood transfusions, and ultimately delivery by cesare
Antepartum hemorrhage (APH) is vaginal bleeding occurring between 24 weeks of pregnancy and birth. It affects 3-5% of pregnancies and can range from light spotting to heavy bleeding with signs of shock. The main causes are placenta previa, placental abruption, and unknown origins. APH poses risks to both mother and fetus, including anemia, infection, shock, and fetal hypoxia. Diagnosis involves examination, ultrasound, and tests. Management depends on gestational age and severity of bleeding, and may involve admission, monitoring, resuscitation, corticosteroids, tocolysis, and delivery.
This document discusses various causes of obstetric haemorrhage including placenta praevia, abruptio placentae, uterine rupture, and vasa previa. It provides details on the definition, risk factors, clinical presentation, diagnosis, and management of each condition. Placenta praevia is defined as a placenta implanted in the lower uterus and is a leading cause of late pregnancy bleeding. Abruptio placentae is the premature detachment of a normally situated placenta before delivery. Uterine rupture is a complete separation of the uterine wall while vasa previa occurs when fetal vessels traverse the membranes over the cervical os. Immediate surgical intervention is often required to treat bleeding
Bleeding in early pregnancy can be due to miscarriage, ectopic pregnancy, or other causes. Signs and symptoms may include vaginal bleeding, abdominal or pelvic pain, and a positive pregnancy test. Evaluation involves assessing the last menstrual period, risk factors, ultrasound findings, and serum hCG levels. Management depends on the diagnosis and clinical situation, and may involve expectant monitoring, medical treatment with misoprostol or methotrexate, or surgical evacuation. The goal is to identify life-threatening ectopic pregnancies while preserving future fertility when possible.
This document discusses antepartum haemorrhage (APH), defined as bleeding from or into the genital tract between 22 weeks of pregnancy and birth. It affects 3-5% of pregnancies and is a leading cause of perinatal mortality. The main causes of APH are placenta praevia, abruptio placentae, vasa praevia, and local cervical/vaginal bleeding. Management depends on severity and etiology, and may include bed rest, corticosteroids, monitoring, blood transfusion, and delivery by vaginal birth or caesarean section.
Postpartum hemorrhage (PPH) is excessive bleeding following childbirth. It is a leading cause of maternal mortality, accounting for nearly 1/4 of maternal deaths worldwide. The most common cause is uterine atony, or failure of the uterus to contract after delivery. Other causes include retained placenta, trauma during delivery, coagulation disorders, and issues like placenta previa. Risk factors include previous PPH, macrosomia, multiple pregnancy, and uterine overdistention. Prevention focuses on risk assessment and active management of the third stage of labor. Treatment depends on the severity but may include uterine massage, uterotonic drugs, uterine packing, arterial ligation, embolization, compression sutures
Postpartum hemorrhage (PPH) is excessive bleeding following childbirth. It is a leading cause of maternal mortality, accounting for nearly one quarter of maternal deaths worldwide. The most common cause is uterine atony, or failure of the uterus to contract after delivery. Other causes include retained placenta, trauma during delivery, coagulation disorders, and issues like placenta previa. Risk factors include previous PPH, macrosomia, multiple pregnancy, and uterine overdistention. Prevention focuses on risk assessment and active management of the third stage of labor. Treatment depends on the severity but may include uterine massage, uterotonic drugs, uterine packing, arterial ligation, embolization, compression sutures,
Antepartum haemorrhage (APH) is bleeding from the genital tract between 28 weeks of pregnancy until birth. Placental causes account for 70% of APH cases, with placenta previa being the most common cause, occurring in 35% of placental APH cases. Placenta previa is when the placenta implants partially or completely in the lower uterine segment. It is diagnosed using ultrasound and managed either expectantly until 37 weeks if mild, or through caesarean section, especially for posterior placenta previa or heavy bleeding. Management depends on the amount of bleeding, maternal and fetal condition, and gestational age.
Antepartum haemorrhage (APH), or bleeding during pregnancy, can be caused by placenta praevia or abruption. Placenta praevia occurs when the placenta implants in the lower uterine segment, potentially causing bleeding as the cervix dilates. Abruption occurs when the placenta prematurely separates from the uterine wall, and bleeding severity is classified from mild to severe. APH is considered an obstetric emergency treated initially with IV fluids and monitoring, with management depending on gestational age and bleeding severity, and potentially involving delivery.
This document discusses two cases of high risk obstetrics. Case 1 involves a woman at 34 weeks gestation presenting with abdominal pain and bleeding. Her examination and investigations indicate signs of placental abruption. Case 2 involves a woman at 34.5 weeks gestation with a history of two previous cesarean sections and placenta previa diagnosed at 21 weeks. Her examination and ultrasound confirm placenta previa and possible placenta accreta. The document then discusses various questions related to the differential diagnosis, risk factors, complications, management, and delivery approach for conditions like placental abruption and placenta previa.
This document discusses placenta previa and placenta accreta spectrum. It begins with definitions of placenta previa as implantation of the placenta over the internal cervical os. It describes placenta accreta spectrum from accreta where the placenta attaches to the myometrium without decidua, to increta with invasion into the myometrium, and percreta with invasion through the myometrium. Risk factors include placenta previa, cesarean sections, advanced maternal age, and previous uterine surgeries. Ultrasound is the main diagnostic tool but MRI can also be used. Management involves multidisciplinary care, conservative approaches when possible
Antepartum haemorrhage (APH), or bleeding during pregnancy, can be caused by placenta praevia or abruption placentae. Placenta praevia occurs when the placenta implants in the lower uterine segment, potentially causing bleeding as the cervix dilates. Abruptio placentae involves premature separation of a normally implanted placenta from the uterus, and risks include hypertension, smoking, and trauma. APH is a medical emergency treated initially with IV fluids and blood transfusions, with management depending on gestational age and severity of bleeding, potentially involving bed rest, corticosteroids, or caesarean delivery.
1) Antepartum haemorrhage is defined as bleeding from or into the genital tract after 28 weeks of pregnancy but before birth. Placenta praevia and abruption placentae are two common causes.
2) Placenta praevia occurs when the placenta implants partially or fully in the lower uterine segment. It can cause painless vaginal bleeding and is diagnosed using ultrasound.
3) Abruption placentae is the premature separation of a normally implanted placenta and can cause abdominal pain with concealed or mixed internal and external bleeding. It is commonly associated with preeclampsia.
This document discusses various causes of antepartum hemorrhage (APH), including placenta previa, abruption placentae, and vasa previa. Placenta previa, where the placenta implants in the lower uterine segment, accounts for about one-third of APH cases. Risk factors include advancing maternal age, multiparity, prior cesarean delivery, and smoking. Management depends on gestational age and severity of bleeding, ranging from bed rest to cesarean delivery. Abruptio placentae is the premature separation of a normally implanted placenta and can cause concealed or revealed bleeding. It is associated with increased risks of fetal and maternal complications. Vasa previa
This document discusses third-trimester bleeding during pregnancy. It can be caused by conditions like abruptio placentae (AP), placenta previa (PP), and vasa previa (VP). AP is the premature separation of the placenta from the uterine wall. PP is the presence of placental tissue over the cervical os. VP occurs when umbilical cord vessels lie in the membranes over the cervical os. These conditions can lead to significant maternal and fetal risks if not properly managed. The document outlines the epidemiology, etiology, complications, diagnosis, and management considerations for each condition.
This document discusses the evaluation and management of a 37-year-old pregnant female presenting with vaginal bleeding. The differential diagnosis includes placenta previa. Ultrasound confirms placenta previa. The types of placenta previa and risk factors are discussed. As the bleeding increases and vital signs deteriorate, urgent delivery by cesarean section is required to stabilize the patient.
Late pregnancy bleeding can be caused by placental, fetal, or maternal factors. Placental causes include placental abruption and placenta previa. Initial evaluation includes assessing vital signs, fetal heart tones, nature of bleeding, and ultrasound to locate the placenta. Placental abruption involves premature separation of the placenta and can range from mild to severe. Placenta previa occurs when the placenta covers all or part of the cervical os, posing risks of hemorrhage. Morbidly adherent placenta like placenta accreta involves abnormal invasion of the placenta into the uterine wall. Vasa previa is a rare condition where fetal vessels cross the internal
anti partum hemorrhage and its complicationdevtesfaye77
1. Antepartum hemorrhage (APH) refers to vaginal bleeding after 28 weeks of gestation until delivery. The leading causes are placental abruption and placenta previa. Placental abruption is the premature separation of a normally implanted placenta and can range from mild to severe based on the extent of separation. Placenta previa involves the placenta covering or lying adjacent to the cervical os, posing a risk of painless bleeding. Less common, vasa previa occurs when fetal blood vessels lie over the cervical os.
2. Diagnosis involves clinical presentation as well as ultrasound and laboratory testing. Management depends on severity, gestational age and maternal-fetal
Similar to Antepartum Haemorrhage Presentation- Dr. Jauyo.pdf (20)
Mercurius is named after the roman god mercurius, the god of trade and science. The planet mercurius is named after the same god. Mercurius is sometimes called hydrargyrum, means ‘watery silver’. Its shine and colour are very similar to silver, but mercury is a fluid at room temperatures. The name quick silver is a translation of hydrargyrum, where the word quick describes its tendency to scatter away in all directions.
The droplets have a tendency to conglomerate to one big mass, but on being shaken they fall apart into countless little droplets again. It is used to ignite explosives, like mercury fulminate, the explosive character is one of its general themes.
- Video recording of this lecture in English language: https://youtu.be/Pt1nA32sdHQ
- Video recording of this lecture in Arabic language: https://youtu.be/uFdc9F0rlP0
- Link to download the book free: https://nephrotube.blogspot.com/p/nephrotube-nephrology-books.html
- Link to NephroTube website: www.NephroTube.com
- Link to NephroTube social media accounts: https://nephrotube.blogspot.com/p/join-nephrotube-on-social-media.html
These lecture slides, by Dr Sidra Arshad, offer a simplified look into the mechanisms involved in the regulation of respiration:
Learning objectives:
1. Describe the organisation of respiratory center
2. Describe the nervous control of inspiration and respiratory rhythm
3. Describe the functions of the dorsal and respiratory groups of neurons
4. Describe the influences of the Pneumotaxic and Apneustic centers
5. Explain the role of Hering-Breur inflation reflex in regulation of inspiration
6. Explain the role of central chemoreceptors in regulation of respiration
7. Explain the role of peripheral chemoreceptors in regulation of respiration
8. Explain the regulation of respiration during exercise
9. Integrate the respiratory regulatory mechanisms
10. Describe the Cheyne-Stokes breathing
Study Resources:
1. Chapter 42, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 36, Ganong’s Review of Medical Physiology, 26th edition
3. Chapter 13, Human Physiology by Lauralee Sherwood, 9th edition
Clinic ^%[+27633867063*Abortion Pills For Sale In Tembisa Central19various
Clinic ^%[+27633867063*Abortion Pills For Sale In Tembisa Central Clinic ^%[+27633867063*Abortion Pills For Sale In Tembisa CentralClinic ^%[+27633867063*Abortion Pills For Sale In Tembisa CentralClinic ^%[+27633867063*Abortion Pills For Sale In Tembisa CentralClinic ^%[+27633867063*Abortion Pills For Sale In Tembisa Central
Osteoporosis - Definition , Evaluation and Management .pdfJim Jacob Roy
Osteoporosis is an increasing cause of morbidity among the elderly.
In this document , a brief outline of osteoporosis is given , including the risk factors of osteoporosis fractures , the indications for testing bone mineral density and the management of osteoporosis
Kosmoderma Academy, a leading institution in the field of dermatology and aesthetics, offers comprehensive courses in cosmetology and trichology. Our specialized courses on PRP (Hair), DR+Growth Factor, GFC, and Qr678 are designed to equip practitioners with advanced skills and knowledge to excel in hair restoration and growth treatments.
5-hydroxytryptamine or 5-HT or Serotonin is a neurotransmitter that serves a range of roles in the human body. It is sometimes referred to as the happy chemical since it promotes overall well-being and happiness.
It is mostly found in the brain, intestines, and blood platelets.
5-HT is utilised to transport messages between nerve cells, is known to be involved in smooth muscle contraction, and adds to overall well-being and pleasure, among other benefits. 5-HT regulates the body's sleep-wake cycles and internal clock by acting as a precursor to melatonin.
It is hypothesised to regulate hunger, emotions, motor, cognitive, and autonomic processes.
10 Benefits an EPCR Software should Bring to EMS Organizations Traumasoft LLC
The benefits of an ePCR solution should extend to the whole EMS organization, not just certain groups of people or certain departments. It should provide more than just a form for entering and a database for storing information. It should also include a workflow of how information is communicated, used and stored across the entire organization.
Cell Therapy Expansion and Challenges in Autoimmune DiseaseHealth Advances
There is increasing confidence that cell therapies will soon play a role in the treatment of autoimmune disorders, but the extent of this impact remains to be seen. Early readouts on autologous CAR-Ts in lupus are encouraging, but manufacturing and cost limitations are likely to restrict access to highly refractory patients. Allogeneic CAR-Ts have the potential to broaden access to earlier lines of treatment due to their inherent cost benefits, however they will need to demonstrate comparable or improved efficacy to established modalities.
In addition to infrastructure and capacity constraints, CAR-Ts face a very different risk-benefit dynamic in autoimmune compared to oncology, highlighting the need for tolerable therapies with low adverse event risk. CAR-NK and Treg-based therapies are also being developed in certain autoimmune disorders and may demonstrate favorable safety profiles. Several novel non-cell therapies such as bispecific antibodies, nanobodies, and RNAi drugs, may also offer future alternative competitive solutions with variable value propositions.
Widespread adoption of cell therapies will not only require strong efficacy and safety data, but also adapted pricing and access strategies. At oncology-based price points, CAR-Ts are unlikely to achieve broad market access in autoimmune disorders, with eligible patient populations that are potentially orders of magnitude greater than the number of currently addressable cancer patients. Developers have made strides towards reducing cell therapy COGS while improving manufacturing efficiency, but payors will inevitably restrict access until more sustainable pricing is achieved.
Despite these headwinds, industry leaders and investors remain confident that cell therapies are poised to address significant unmet need in patients suffering from autoimmune disorders. However, the extent of this impact on the treatment landscape remains to be seen, as the industry rapidly approaches an inflection point.
Adhd Medication Shortage Uk - trinexpharmacy.comreignlana06
The UK is currently facing a Adhd Medication Shortage Uk, which has left many patients and their families grappling with uncertainty and frustration. ADHD, or Attention Deficit Hyperactivity Disorder, is a chronic condition that requires consistent medication to manage effectively. This shortage has highlighted the critical role these medications play in the daily lives of those affected by ADHD. Contact : +1 (747) 209 – 3649 E-mail : sales@trinexpharmacy.com
The skin is the largest organ and its health plays a vital role among the other sense organs. The skin concerns like acne breakout, psoriasis, or anything similar along the lines, finding a qualified and experienced dermatologist becomes paramount.
Travel Clinic Cardiff: Health Advice for International TravelersNX Healthcare
Travel Clinic Cardiff offers comprehensive travel health services, including vaccinations, travel advice, and preventive care for international travelers. Our expert team ensures you are well-prepared and protected for your journey, providing personalized consultations tailored to your destination. Conveniently located in Cardiff, we help you travel with confidence and peace of mind. Visit us: www.nxhealthcare.co.uk
Travel vaccination in Manchester offers comprehensive immunization services for individuals planning international trips. Expert healthcare providers administer vaccines tailored to your destination, ensuring you stay protected against various diseases. Conveniently located clinics and flexible appointment options make it easy to get the necessary shots before your journey. Stay healthy and travel with confidence by getting vaccinated in Manchester. Visit us: www.nxhealthcare.co.uk
2. Definition
Defined as:
■ Bleeding from or in to the genital tract, occurring from 24
weeks (>500g) of pregnancy and prior to the birth of the
baby.
■ Complicates 3–5% of pregnancies.
■ Leading cause of perinatal and maternal mortality
worldwide.
■ Up to one-fifth of very preterm babies are born in
association with APH
■ Most of the time unpredictable.
APH
3. Severity
Assessing severity:
■ No consistent definitions of the severity of APH.
■ Amount of blood lost is often underestimated.
■ Amount of blood coming from the introitus may not
represent the total blood lost ( e.g in a concealed placental
abruption).
■ It is important to assess for signs of clinical shock.
■ The presence of fetal compromise or fetal demise is an
important indicator of volume depletion.
APH
4. Severity cont’d
But maybe:
■ Spotting – staining, streaking or blood spotting noted on
underwear or sanitary protection.
■ Minor haemorrhage – blood loss less than 50 ml that
has settled.
■ Major haemorrhage – blood loss of 50–1000 ml, with
no signs of clinical shock.
■ Massive haemorrhage – blood loss greater than 1000
ml and/or signs of clinical shock.
■ Recurrent APH- > one episode.
PMTCT
6. A 34-year-old multigravida at 31 weeks’
gestation comes to the labor unit stating she
woke up in the middle of the night in a pool
of blood. She denies pain or uterine
contractions. Examination of the uterus
shows the fetus to be in transverse lie. Fetal
heart sounds are regular at 145 beats/min.
On inspection her perineum is grossly
bloody
10. What are the risk factors for placenta praevia?
Abruption is more likely to be related to
conditions occurring during pregnancy
and placenta praevia is more
likely to be related to conditions
existing prior to pregnancy.
11. Risk factors for placenta praevia?
■ Previous placenta praevia (4-8%)
■ Previous caesarean sections ( risk with numbers of c-section)
■ Previous termination of pregnancy
■ Multiparity
■ Advanced maternal age (>40 years)
■ Multiple pregnancy
■ Smoking
■ Deficient endometrium due to presence or history of:
● uterine scar
● endometritis
● manual removal of placenta
● curettage
● submucous fibroid APH
12. A 32-year-old multigravida at 31 weeks’
gestation is admitted to the labor
unit after a motor-vehicle accident. She
complains of sudden onset of moderate
vaginal bleeding for the past hour. She has
intense, constant uterine pain
and frequent contractions. Fetal heart
sounds are regular at 145 beats/min. On
inspection her perineum is grossly bloody.
13. Abruptio Placenta (AP)
■ Separation of normally located placenta after 22 weeks of
gestation ( > 500g) and prior to delivery of fetus.
PMTCT
15. What are the risk factors for Abruptio Placenta?
Abruption is more likely to be
related to conditions occurring
during pregnancy and placenta
praevia is more likely to be related to
conditions existing prior to pregnancy.
16. Risk factors for Abruptio Placenta ?
■ Previous history of AP
■ Maternal hypertension
■ Advanced maternal age
■ Trauma ( domestic violence, accident, fall)
■ Polyhydramnios
■ Intrauterine infections
■ Non-vertex presentations
■ Short umbilical cord
■ Sudden decompression of uterus (PROM/delivery of 1st twins)
■ Retroplacental fibroids
■ Fetal growth restriction
APH
17. Risk factors for Abruptio Placenta ?
■ Smoking/alcohol/cocaine/amphetamines
■ Low body mass index (BMI)
■ Idiopathic
■ First trimester bleeding increases the risk of abruption later in
the pregnancy
■ When an intrauterine haematoma is identified on ultrasound
scan in the first trimester, the risk of subsequent placental
abruption is increased
APH
18. Abruptio Placenta
■ Diagnosed CLINICALLY
● Painful vaginal bleeding -80%
● Tense/woody hard, and tender abdomen/back pain
(70%) increase in fundal height
● Fetal distress ( 60%)
● Abnormal uterine contractions (hypertonic and high
frequency)
● Preterm labour ( 25%)
● Fetal death ( 15%)
● Ultrasound is NOT USEFUL to diagnose AP;
retroplacental clots (hyperechoic) easily missed
19. Vasa Praevia (VP)
● Present when fetal
vessels traverse
the fetal
membranes over
the internal
cervical os.
PMTCT
20. Vasa Praevia (VP)
■ Antenatal diagnosis – reduced perinatal mortality and morbidity.
■ Painless vaginal bleeding at the time of spontaneous rupture of
membrane or post amniotomy
■ Fetal bradycardia;
■ Fetal shock or death can occur rapidly at the time of diagnosis
due to mainly fetal blood loss; blood volume in fetus ( 3kg
fetus~300ml)
■ ALWAYS check the FHR after rupture of membrane or
amniotomy.
■ Definitive diagnosis by inspecting the placenta and fetal
membrane after delivery.
21. Reminder!!
A 27-yo G2 P1 woman comes to the maternity unit for
evaluation for regular uterine contractions at 34 weeks’
gestation. Her previous delivery was an emergency CS at
32 weeks because of hemorrhage from placenta previa. A
classical uterine incision was used because of lower uterine
segment varicosities. Pelvic exam shows the cervix to be
closed and long. As she is being evaluated, she experiences
sudden abdominal pain, profuse vaginal bleeding, and fetal
bradycardia. Uterine contractions cannot be detected. The
fetal head, which was at –1 station, now is floating.
24. Clinical assessment in APH
Initial: Primary Survey~~~ ABCD
● First and foremost: Mother and fetal well being (mother is the
priority)
● Establish whether urgent intervention is required to manage
maternal or fetal compromise.
● Assess the extent of vaginal bleeding, cardiovascular condition of
the mother
● Assess fetal wellbeing
APH
25. Full History
Taken after the mother is stable:
■ Associated pain with the bleeding?
● Continuous pain: Placental abruption.
● Intermittent pain: Labour.
■ Risk factors for abruption and placenta praevia should be
identified.
■ Reduced fetal movements?
■ If APH is associated with spontaneous or AROM: ruptured vasa
praevia
■ Previous cervical smear history; possibility of Ca cervix.
Symptomatic pregnant women present with APH (mostly
postcoital) or vaginal discharge.
26. Examination
■ General: PULSE & BP (a MUST!)
■ Abdomen:
● The tense, tender or ‘woody’ feel to the uterus
indicates a significant abruption.
● Uterine contractions– mild, moderate, strong
● Abnormal uterine contractions (hypertonic
and high frequency)
● Progressive increase in fundal height?–
concealed, major abruption?
27. Examination cont’d
■ Abdomen:
● Painless bleeding, high fetal presenting part –
Placenta praevia
● Soft, non-tender uterus may suggest a lower
genital tract cause or bleeding from placenta or
vasa praevia
28. Examination cont’d
■ Speculum :
● Identify cervical dilatation or visualize a lower
genital tract cause.
■ Digital vaginal examination
● Should NOT be done until Placenta Praevia
has been excluded by USG if suspicious for PP
● Can provide information on cervical dilatation
if APH is associated with pain or uterine
activity
29. Investigations
■ FBC (HB, Platelets) UEC, LFT, Coagulation profile,
■ GXM 4 units,
■ Ultrasound- r/o PP & IFUD ***does not exclude abruption***
■ D-dimer : AP
■ Colour doppler TVS – VP
■ In all women who are RhD-negative, a Kleihauer test should be
performed to quantify FMH to gauge the dose of anti-D Ig
required.
■ Fetal monitoring: FHR, CTG monitoring
30. Management
The four pillars of management:
■ communication between all members of the
multidisciplinary team
■ resuscitation
■ monitoring and investigation
■ arrest bleeding by arranging delivery of the
fetus
31. Management cont’d
WHEN to admit?
■ Based on individual assessment
■ Discharge after reassurance and counselling danger signs
● Presenting with spotting, no longer bleeding and
placenta praevia has been excluded.
● However, spotting + previous IUFD due to placenta
abruption, an admission would be appropriate.
■ All women with APH heavier than spotting and women
with ongoing bleeding should remain in hospital at least
until the bleeding has stopped.
32. Management cont’d
■ If preterm delivery is anticipated, a single course of
antenatal corticosteroids (dexamethasone 12mg 12
hourly, 2 doses) to women between 24 and 34 weeks 6
days of gestation.
■ Tocolytics - not to be used to delay delivery in major
APH, or haemodynamically unstable, or if there is
evidence of fetal compromise.
■ For very preterm (24-26 weeks),
● Conservative management if mother is stable .
● Delivery of fetus – life threatening
● Experienced neonatologists should be involved
33. Management cont’d
For Placenta Praevia
■ Conservative:
● Premature < 37 weeks; mother haemodynamically
stable, no active bleeding, fetus stable
● Advise bed rest, keep pad chart, vital signs
monitoring , Ultrasound, steroids, GSH, Daily
● CTG and biophysical profile, fetal movement count.
■ Plan for CS delivery
● >37 weeks. Crossmatch 4 units of blood.
34. Management cont’d
For Abruptio placenta, (obs emergency!!)
■ ABC, high flow O2, aggressive fluid resuscitation
■ Continuous vital signs monitoring and urine output
■ Monitor vaginal bleeding – strict pad chart
■ Continuous CTG for fetal heart rate
■ Crossmatch 4 units of blood
■ FFP – coagulopathy
■ Dexamethasone – preterm
■ ** ICU admission: Close monitoring and resuscitation!
35. Management cont’d
For Abruptio placenta, (obs emergency!!)
■ Decide Mode of delivery
● Vaginal delivery – when fetal death,
hemodynamically stable
● Caesarean section
● If maternal/ fetal health compromised
● Indicated when early DIC sets in
● Consent should be taken for hysterectomy in
case bleeding could not be controlled.
Err on the side of caution!!!
36. 1. Should the antenatal care of a woman be altered following
APH?
2. Is it blood-stained show or APH?
3. Any concerns for third stage of labour in women with
APH?
4. Who should be included in the management and
resuscitation team?
5. Any concerns with the APH newborn?
6. Any postnatal issues to be addressed with the woman
&family?
7.